Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp.

Extension period extended 15 months to October 15, 2027 via monthly deposits.
Monthly extension fee set at $75,828.46 (lesser of $100k or $0.033/public share).
1,903,823 ordinary shares tendered for redemption at the extension meeting.
Second amended charter and trust agreement amendment filed effective May 28, 2026.

item 1.01 item 5.03 item 5.07 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-26-063110
form_type: 8-K
ticker: RDAC
cik: 0002018145
company_name: Rising Dragon Acquisition Corp.
filed_at: 2026-06-01T10:08:35+00:00
discovered_at: 2026-06-01T10:10:00.263487+00:00
generated_at: 2026-06-01T10:10:10.962077+00:00
sec_items: ["1.01", "5.03", "5.07", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-26-063110
json_url: https://secwatch.observer/filing/0001213900-26-063110.json
markdown_url: https://secwatch.observer/filing/0001213900-26-063110.md
text_url: https://secwatch.observer/filing/0001213900-26-063110.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/0001213900-26-063110-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/2018145/000121390026063110/ea0292895-8k_rising.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 1.01, 5.03, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 1.01, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

INAB

IN8bio enters new ATM equity facility with JonesTrading, terminates prior Cantor agreement

IN8BIO, INC. June 1, 2026, 6:56 AM ET other_material Items 1.01, 1.02, 9.01

same SEC item: 1.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EAF

GrafTech enters into $50M at-the-market equity distribution agreement with Evercore

GRAFTECH INTERNATIONAL LTD May 29, 2026, 5:26 PM ET other_material Items 1.01, 9.01

same SEC item: 1.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TNYA

Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors

Tenaya Therapeutics, Inc. May 29, 2026, 5:04 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLDI

Calidi Biotherapeutics issues amended warrant for 17.4M shares at $0.23, subject to stockholder approval

Calidi Biotherapeutics, Inc. May 29, 2026, 5:00 PM ET other_material Items 1.01, 3.02, 9.01

same SEC item: 1.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-26-063110

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.